QUANTUM BIOPHAR (QNTM)
(Delayed Data from NSDQ)
$24.57 USD
-3.23 (-11.62%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $24.20 -0.37 (-1.51%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Quantum Biopharma Ltd.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
QNTM 24.57 -3.23(-11.62%)
Will QNTM be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for QNTM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for QNTM
QUANTUM BIOPHAR (QNTM) Upgraded to Buy: Here's What You Should Know
QNTM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for QNTM
Quantum BioPharma (QNTM) Advances Lucid-MS Development Following Positive Trial
Quantum Biopharma Announces Positive Results of the Clinical Study Report (CSR) for the Phase 1 ...
Quantum Group subsidiary received CSR for Phase 1 MAD trial
Quantum BioPharma (QNTM) Counters Motion to Dismiss in Market Manipulation Case
Quantum BioPharma Files Reply and Provides Update on Court Case Seeking Damages Against CIBC, ...